OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
South Korea
· Delayed Price · Currency is KRW 5,940.00
-80.00 (-1.33%)
At close: Mar 31, 2025, 3:30 PM KST
OPTUS Pharmaceutical Revenue
In the year 2024, OPTUS Pharmaceutical had annual revenue of 81.90B KRW with 13.09% growth. OPTUS Pharmaceutical had revenue of 22.98B in the quarter ending December 31, 2024, with 15.60% growth.
Revenue
81.90B
Revenue Growth
+13.09%
P/S Ratio
1.14
Revenue / Employee
515.12M
Employees
159
Market Cap
99.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 81.90B | 9.48B | 13.09% |
| Dec 31, 2023 | 72.43B | 13.77B | 23.47% |
| Dec 31, 2022 | 58.66B | 1.34B | 2.34% |
| Dec 31, 2021 | 57.32B | -3.51B | -5.77% |
| Dec 31, 2020 | 60.83B | 385.58M | 0.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 300.87T |
| SK hynix | 66.19T |
| LG Energy Solution | 25.62T |
| Samsung Biologics | 4,547.32B |
| Hyundai Motor Company | 175.23T |
| Celltrion | 3,557.30B |
| Kia Corporation | 107.45T |
| KB Financial Group | 15.01T |